Distribution Of Lymphatic Filariasis (LF) Treatment across selected region(Amhara, Benshangul Gumuz, Gambela, SNNP, Oromia, South west Ethiopia ,Southern Ethiopia) and Selected woreda, Ethiopia from 2009 to 2025
| Id | EPHI-DS0600 |
|---|---|
| Name | Distribution Of Lymphatic Filariasis (LF) Treatment across selected region(Amhara, Benshangul Gumuz, Gambela, SNNP, Oromia, South west Ethiopia ,Southern Ethiopia) and Selected woreda, Ethiopia from 2009 to 2025 |
| Format | .xlsx |
| Coverage Location | National |
| Coverage Sex | Both |
| Abstract | The data collection occurred over two distinct rounds. Round one was conducted for a specific period, targeting a population of 9,559,839 individuals, while round two followed with an updated population count of 10,147,898 individuals. The variable collected in survey are Type of treatment administered (Round 1: Ivermectin + Albendazole; Round 2: DEC + Albendazole), Total number of individuals who received treatment (Round 1: 7,674,019; Round 2: 8,165,787), Percentage of the population treated relative to the planned population (approximately 80% for both rounds) and Information on co-endemicity of onchocerciasis and other diseases in the surveyed areas. |
| Additional Material | No |
| Keywords |
|
| Recommended | No |
| Location | |
| Cleaned | Yes |
| Cleaned Format | . csdb |
| RawFormat | . csdb |
| Comment | |
| Remark | |
| Note | |
| Treatment | |
| Date Data Collection Started | 2009-01-01 |
| Date Data Collection End | 2025-01-01 |
| Title | Distribution Of Lymphatic Filariasis (LF) Treatment across selected region(Amhara, Benshangul Gumuz, Gambela, SNNP, Oromia, South west Ethiopia ,Southern Ethiopia) and woreda, Ethiopia from 2009 to 2025 |
| Data Type | Surveillance |
| PublicationYear | 2000 |
| SugestedCitation | |
| OtherIdType | |
| Description | The data was collected through a longitudinal survey conducted in risk-prone regions and woredas. The survey might have utilized health records, community health worker reports, and direct interviews with the population to gather information on treatment uptake. The data collection occurred over two distinct rounds. Round one was conducted for a specific period, targeting a population of 9,559,839 individuals, while round two followed with an updated population count of 10,147,898 individuals. The variable collected in survey are Type of treatment administered (Round 1: Ivermectin + Albendazole; Round 2: DEC + Albendazole), Total number of individuals who received treatment (Round 1: 7,674,019; Round 2: 8,165,787), Percentage of the population treated relative to the planned population (approximately 80% for both rounds) and Information on co-endemicity of onchocerciasis and other diseases in the surveyed areas. |
| Dataset study design | Cross-sectional survey |
| Date Data Archived | 2026-06-09 |
| Date Data Cataloged | 2026-07-21 |
| Data Generating Unit | Ethiopian Public Health Institute (EPHI) |
| URL | https://rtds.ephi.gov.et/public/showdetail/600 |
| Tags |
|
Open Access